Studies testing the protective efficacy of Tc24, TSA1 (individually or in combination, [33]) or other antigens (reviewed in [7,20,21]) have shown the protection associated with the induction of CD8+ T cell activity and IFN-γ production; however, in these studies, challenge infection was conducted immediately after vaccination. The gene discussed is CD8A; the disease is infection.